Zoetis Inc. Unrecognized Tax Benefits, Interest on Income Taxes Accrued
Zoetis Inc. (ZTS) had Unrecognized Tax Benefits, Interest on Income Taxes Accrued of $51.00 million as of 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties › Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued
us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued · last filed 2026-02-12
- 2025-12-31: Unrecognized Tax Benefits, Interest on Income Taxes Accrued $51.00M.
- 2024-12-31: Unrecognized Tax Benefits, Interest on Income Taxes Accrued $37.00M.
- 2023-12-31: Unrecognized Tax Benefits, Interest on Income Taxes Accrued $26.00M.
- 2022-12-31: Unrecognized Tax Benefits, Interest on Income Taxes Accrued $16.00M.
| Period end | Unrecognized Tax Benefits, Interest on Income Taxes Accrued | Unrecognized Tax Benefits, Interest on Income Taxes Accrued as first filed |
|---|---|---|
| 2025-12-31 | $51.00M 10-K · filed 2026-02-12 | |
| 2024-12-31 | $37.00M 10-K · filed 2026-02-12 | |
| 2023-12-31 | $26.00M 10-K · filed 2026-02-12 | |
| 2022-12-31 | $16.00M 10-K · filed 2025-02-13 | |
| 2021-12-31 | $12.00M 10-K · filed 2024-02-13 | |
| 2020-12-31 | $11.00M 10-K · filed 2023-02-14 | |
| 2019-12-31 | $9.00M 10-K · filed 2022-02-15 | |
| 2018-12-31 | $8.00M 10-K · filed 2021-02-16 | |
| 2017-12-31 | $7.00M 10-K · filed 2020-02-13 | |
| 2016-12-31 | $6.00M 10-K · filed 2019-02-14 | |
| 2015-12-31 | $4.00M 10-K · filed 2018-02-15 | |
| 2014-12-31 | $3.00M 10-K · filed 2017-02-16 | $4.00M 10-K · filed 2015-02-27 |
| 2013-12-31 | $11.00M 10-K · filed 2015-02-27 | |
| 2012-12-31 | $17.00M 10-K · filed 2014-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |